Hims & Hor to acquire Zava, a European Telegesundheit platform
The HIMS logo arranged on a smartphone in New York on February 12, 2025.
Bloomberg | Bloomberg | Getty pictures
Hims & Hers Health On Tuesday it will be announced that it will acquire European telemedicine platform Zava to expand worldwide.
“We look forward to taking this moment to accelerate both European expansion, but also to use this platform as an acceleration if we enter further markets,” Andrew Dudum, CEO from HIMS & HERS, told CNBC in an interview.
According to the company's press release, the deal will be completed by the middle of the year. While the acquisitions have not been disclosed, the details of the transaction will be available in the event of the financial disclosure.
Dudum spoke in detail during the company in the first quarter of the company in mid -May about the company's commitment to global expansion.
“Early traction in Great Britain gives us the confidence that we can scale the platform worldwide and expand the mission to help people around the world,” said Dudum at that time.
HIMS first expanded his global footprint to Great Britain in 2021 when it took over the vertical health platform of the honesty health in London.
The deal for the acquisition of Zava will expand the company's services to Ireland, France and Germany and expand its active customer base by around 50%, which gives 1.3 million customers of the existing basis of 2.4 million subscribers from 1.3 million customers.
The CEO of Zava, David Meinertz, who started the platform in 2011, said that the deal would provide relief.
“The medication are more competitive than in the USA, so that more people can actually afford it and we see enormous demand,” said Meinz. “Demand increases with additional tribes on the legal systems that telemedicine can alleviate.”
In the European Union, the legal health system generally refers to the publicly financed health insurance and health care systems in individual Member States. These systems are universal and offer citizens and residents a comprehensive coverage, although access and cover can vary.
After completing the acquisition, Zava platforms will maintain their branding for a few “quarters” before being renamed as Hims & Hein, said Dudum. Meinertz becomes general manager of the international company.
Dudum noted that some companies withdraw their growth prospects in the face of macroeconomic uncertainty, but it has full confidence that it is the right decision to penetrate.
“The pricing for medicines is much more advantageous in a broader Europe compared to the United States,” said Dudum. “The ability to bring customers accessible in overseas, personalized treatments [pharmacy benefit managers] And the pricing that exists here. “
